Analytical performance of self-collection methods for cervical cancer screening

In terms of analytical performance, there is solid evidence that there is good agreement between a set of patients who self-collected sample and a clinician collected sample. 

Current status of- & innovations in cervical cancer screening

The main innovation in cervical cancer screening is the switch from cervical cytology to HR-HPV testing as a preliminary screen (as a rule out test). An important attribute of HR-HPV is that because it is more sensitive than cervical cytology for cervical precancer and cancer, it permits a safe extension of screening intervals among the negatives, which then results in less harm due to screening and potentially lower costs.

Technology pulse: Opportunties with a twist

In the December 2012 issue of GEN, it was reported that by 2014 the global in vitro diagnostics (IVD) market is forecasted to surpass the $50 billion milestone. The two key drivers of demand are infectious disease testing and an aging population that is growing more susceptible to chronic disease such as arthritis, autoimmune diseases, asthma, diabetes, and cardiovascular diseases and cancer (which accounts for 12.5% of all deaths worldwide, more than HIV/AIDS, TB and malaria combined). Molecular diagnostics, which makes up more than 10% of the market, is one of the fastest growing segments with an 11% CAGR forecast. Together this means that molecular diagnostics will play an important role in these two market drivers.

Independent, peer-reviewed papers highlight the usefulness of FTA™ cards in specific DNA applications

We have identified a series of independent, peer-reviewed papers that highlight the usefulness of FTA™ cards in specific DNA applications, and in which you will find useful ideas, hints and tips for the use of FTA cards in your sample collection. The abstracts and conclusions from the first two papers are included below.

Subscribe to our Blog and Twitter feed to stay up to date with the latest news, views and developments in the world of diagnostics!

This blog will keep you up to date with the latest insights and developments in the fields of genomics, molecular diagnostics, reagents, kits and immunodiagnostics, all the way from R&D to manufacture.